Ambroxol inhibits IgE-dependent mediator secretion from human skin mast cells.
Gibbs
B F
BF
Department of Dermatology, Medical University of Lübeck, Germany.
Wolff
H H
HH
Grabbe
J
J
D000551:Ambroxol / Q000008:administration & dosage / Q000494:pharmacology*; D015550:Cell Degranulation / Q000187:drug effects; D006636:Histamine Release / Q000187:drug effects*; D006801:Humans; D007073:Immunoglobulin E / Q000276:immunology*; D018793:Interleukin-13 / Q000378:metabolism; D015847:Interleukin-4 / Q000378:metabolism; D017997:Leukotriene C4 / Q000378:metabolism; D008407:Mast Cells / Q000187:drug effects / Q000276:immunology* / Q000502:physiology; D012867:Skin / Q000166:cytology*
D018793:Interleukin-13; D000551:Ambroxol; D015847:Interleukin-4; D017997:Leukotriene C4; D007073:Immunoglobulin E